Before I could even get one cup of coffee down the hatch this morning, I was hit with a barrage of emails, texts, and phone calls asking me for quotes concerning the press release issued by Moderna regarding their decision to sue BioNTech/Pfizer for patent infringement relating to the insanely profitable SARS-CoV-2 mRNA "vaccine" products marketed by BioNTech/Pfizer ("Comirnaty" – licensed but not actually marketed in the USA). What I had hoped to do today was put on my work clothes and go pick up the ditch trencher that I had reserved so that we can get fiber optic cable laid down between the various buildings that form our farm compound, including the new recording studio. And to try to finish editing on the book – "The lies my government told me and the better future coming". But no, once again the tyranny of the urgent has ambushed me, and like a shakedown in a NY City alley, I must comply.

Let's dive into this. I have done the diligence, reviewed the (amazingly superficial) press coverage which has been printed on this topic, and have already responded to three different interview and statement requests. Hopefully, by putting my thoughts down in the form of a substack article, I can just refer future inquires to this analysis.

Among the many things I have learned about the corporate (and academic) press over the last three years it is how completely incompetent they are when it comes to being able to read and understand patents. This really became apparent during the concerted efforts made by corporate press, scientific press (including the NEJM), wikipedia editors, and U Penn/BioNTech seeking to claim that Kariko and Weissman came up with the invention , to Paul Offit making derisive statements in a podcast interview and in the New England Journal of Medicine. All of which intentionally and willfully disregard the nine issued patents (for which I am a co-inventor) which refute these claims. Note that Paul Offit, for example, is employed by the same university as Kariko and Weissman (UPenn), and for which patent UPenn receives quite significant patent royalty payments. This one by STAT news is particularly egregious. "Loose idea" – 9 issued US patents?